Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Page 834

WorkBoard chalks up $23m in series B

Workday joined existing investor Microsoft in a round that will support the development of WorkBoard's enterprise planning software, taking its total funding to $35m.

Mar 26, 2019

HoneyBook folds in $28m

The Citi Ventures-led round increased the total raised by the freelance business and financial planning service to $60m in the past five years.

Mar 26, 2019

IPlytics dives into funding

TU Berlin spinout IPlytics has collected several million dollars from investors including High-Tech Gründerfonds to expand into the US, South Korea and Japan.

Mar 26, 2019

MX Federation adds Bertelsmann to series C1 mix

GLP-backed BitRock Capital has led an eight-figure dollar round for the digital wealth management platform that also featured existing backer BAI.

Mar 26, 2019

Hesus ascends with corporate funding

Bouygues Construction and Suez Group have both contributed to an $11.3m round that will fund the construction waste removal service's European expansion.

Mar 26, 2019

Meyer Burger manufactures Oxford PV stake

Meyer Burger picked up an 18% share in solar film manufacturing spinout Oxford PV, following a recent $41m first series D close for the spinout.

Mar 25, 2019

Delhivery picks up another $413m

Three weeks after reports suggested SoftBank Vision Fund had led a $395m series F round for e-commerce delivery service Delhivery, the size has been confirmed as $413m.

Mar 25, 2019

Ke collects Tencent on its way to $800m

The Lianjia spinoff is currently raising $800m in a series D round that will be led by Tencent, and which looks likely to be its first external funding.

Mar 25, 2019

Carbon Engineering unearths $68m

Chevron, Occidental Petroleum, BHP and Bethel Lands all invested in a round that will fund further testing of Carbon Enginnering's carbon capture technology.

Mar 25, 2019

Pfizer visits Vivet with $51m

Pharmaceutical firm Pfizer has acquired a 15% stake in the gene therapy developer along with an exclusive option to fully buy the Novartis-backed company.

Mar 25, 2019
© 2026 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here